-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 18, the Hebei Provincial Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of the Beijing-Tianjin-Hebei "3+N" Alliance Drug Co-procurement Implementation Work".
Since July 1, 2021, all procurement entities in the province will have a comprehensive Carry out the results of the selection of the Beijing-Tianjin-Hebei "3+N" alliance drug joint procurement
.
The five drugs purchased in this centralized purchase are all hypertension drugs, including 5 varieties of Nicergoline, Torasemide, Carvedilol, Indapamide, and Felodipine:
The results of the selection of the Beijing-Tianjin-Hebei "3+N" alliance drug joint procurement
The Hebei Provincial Medical Insurance Bureau also announced supporting policies:
Do a good job in the coordination of selected prices and medical insurance payment standards
Do a good job in the coordination of selected prices and medical insurance payment standardsFor the centralized purchase of drugs in the medical insurance catalog, the selected price shall be used as the medical insurance payment standard
.
For generic drugs that have not been selected under the same generic name and have not passed the consistency evaluation, the selected price will be used as the medical insurance payment standard; the online price of original research drugs, reference preparations, and generic drugs that have passed the consistency evaluation is 2 times higher than the selected price Within (including 2 times), the selected price is used as the medical insurance payment standard, and the online price is more than twice the selected price (excluding 2 times), and the drug can be used as medical insurance at a standard of not higher than 20% of the selected price Payment standard
Policy for retention of medical insurance fund balance
Policy for retention of medical insurance fund balanceIn accordance with the relevant regulations of the "Implementation Opinions on the Retention of Chinese Medical Insurance Funds for Centralized Procurement of Drugs Organized by the State and the Province" (Jiyibaofa [2020] No.
5), the medical insurance departments of the coordinating districts have dealt with the Beijing-Tianjin-Hebei "3+N" alliance drug joint belt Implement medical insurance fund budget management for mass-purchased varieties
.
The saved part of medical insurance funds will be retained by medical institutions according to the proportion of not more than 50% after passing the assessment
Other supporting policies
Other supporting policiesOther supporting policies and measures for this centralized procurement are implemented in accordance with the "Implementation Plan for Promoting the Normalization and Institutionalization of Centralized Mass Purchase of Drugs" issued by 7 departments including the Provincial Medical Security Bureau, the Provincial Department of Finance, and the Provincial Health and Health Commission (Hebei Medical Insurance Regulations [2021] ] No.
